Top 10 Companies in the Global Medical Super Absorbent Polymer Market (2026): Market Leaders Powering Global Healthcare

MARKET INSIGHTS

The Global medical super absorbent polymer market size was valued at USD 1.01 billion in 2024. The market is projected to grow from USD 1.06 billion in 2025 to USD 1.52 billion by 2032, exhibiting a CAGR of 5.30% during the forecast period.

Medical super absorbent polymers are advanced materials designed to absorb and retain large amounts of aqueous fluids relative to their own mass. These polymers are characterized by their excellent liquid retention capacity under pressure and are primarily used for moisture management in medical applications. Key product types include Sodium Polyacrylate, Polyacrylate/Polyacrylamide, and other copolymers, which are integral to the functionality of various healthcare products.

The market growth is primarily driven by the rising geriatric population, increased prevalence of chronic wounds and incontinence, and heightened demand for advanced wound care products. Furthermore, the growing focus on hospital‑acquired infection control and the expansion of healthcare infrastructure in emerging economies are significant contributors. Strategic initiatives by leading companies are also propelling the market forward. For example, in March 2024, BASF SE announced a significant capacity expansion for its super absorbent polymer production to meet the rising demand from the medical sector. Evonik Industries, Nippon Shokubai Co. Ltd, and LG Chem are among the other prominent players operating globally with extensive product portfolios.

Global Medical Super Absorbent Polymer Market – View in Detailed Research Report

Top 10 Companies in the Global Medical Super Absorbent Polymer Market (2026)

1. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: High‑performance Sodium Polyacrylate for wound dressings, incontinence products, and surgical drapes

BASF SE leverages its extensive R&D infrastructure and broad polymer chemistry expertise to supply medical‑grade super absorbent polymers that meet stringent biocompatibility and regulatory requirements. The company’s recent capacity expansion in March 2024 positions it to meet the growing demand from hospitals and long‑term care facilities worldwide.

Sustainability & Growth Initiatives: Investment in bio‑based polymer research, expansion of production capacity in Europe and Asia, and development of biodegradable SAP variants to align with green procurement mandates.

• Launched a new biocompatible, sodium polyacrylate line with enhanced gel‑blocking resistance.
• Partnership with major wound‑care manufacturers for joint product development.
• Committed to reducing carbon footprint by 30% by 2030.

2. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Specialty polymer solutions for medical‑grade absorbency and antimicrobial‑enhanced dressings

Evonik’s portfolio focuses on tailored super absorbent polymers that provide optimal moisture management while maintaining skin safety. The company’s regulatory expertise ensures rapid clearance across the FDA and EU MDR markets.

Sustainability & Growth Initiatives: Development of low‑energy production processes, collaboration with research institutions on bio‑based SAPs, and expansion of sales in emerging markets.

• Introduced a new antimicrobial‑infused SAP for pressure ulcer management.
• Opened a dedicated R&D center in Shanghai.
• Achieved ISO 14001 certification for environmental management.

3. Nippon Shokubai Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: High‑purity acrylic acid and polyacrylate for medical and hygiene applications

Nippon Shokubai’s long‑standing expertise in acrylic chemistry underpins its supply of medical‑grade SAPs to leading device manufacturers across Asia‑Pacific.

Sustainability & Growth Initiatives: Investment in petrochemical‑free feedstocks, expansion of production capacity in South Korea, and partnership with Japanese hospitals for clinical trials.

• Launched a new gel‑blocking resistant sodium polyacrylate formulation.
• Partnered with a major Japanese wound‑care brand for joint marketing.
• Committed to achieving zero waste to landfill by 2035.

4. LG Chem Ltd.

Headquarters: Seoul, South Korea
Key Offering: Integrated polymer production for medical absorbents and specialty surgical products

LG Chem’s vertically integrated operations enable it to deliver high‑quality SAPs with consistent performance across diverse medical applications.

Sustainability & Growth Initiatives: Expansion of production lines in China, investment in renewable energy for manufacturing, and development of bio‑based polymer blends.

• Opened a new production facility in Guangzhou.
• Collaborated with Korean medical device companies on smart dressing prototypes.
• Reduced CO₂ emissions by 20% in 2023.

5. SDP Global Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Dedicated super absorbent polymer manufacturing for medical and hygiene grades

SDP Global focuses on producing high‑purity SAPs that meet the stringent requirements of medical device manufacturers worldwide.

Sustainability & Growth Initiatives: Adoption of closed‑loop manufacturing processes, research into cellulose‑based SAPs, and expansion into European markets.

• Launched a new biodegradable SAP line in 2024.
• Established a distribution partnership with a leading UK wound‑care company.
• Implemented a circular economy strategy for polymer waste.

6. Gelok Inc.

Headquarters: San Francisco, USA
Key Offering: Customized super absorbent polymer solutions for niche medical applications

Gelok differentiates itself by providing tailor‑made SAP formulations that meet highly demanding performance specifications for specialized medical devices.

Sustainability & Growth Initiatives: Development of low‑toxicity polymer blends, partnership with US hospitals for clinical validation, and investment in advanced manufacturing technologies.

• Introduced a new gel‑blocking resistant polymer for diabetic foot ulcer dressings.
• Collaborated with a leading US medical device firm on smart dressing prototypes.
• Adopted an ISO 9001‑based quality management system.

7. Lohmann & Rauscher GmbH & Co. KG

Headquarters: Tübingen, Germany
Key Offering: Integration of SAP materials into finished wound‑care products and incontinence devices

As a downstream manufacturer, Lohmann & Rauscher incorporates high‑quality SAPs into its portfolio of wound‑care dressings and absorbent hygiene products.

Sustainability & Growth Initiatives: Commitment to eco‑friendly product design, use of recycled materials in packaging, and development of bio‑based SAPs.

• Launched a new line of eco‑friendly incontinence pads in 2023.
• Partnered with a German hospital network for product trials.
• Achieved a 15% reduction in packaging waste.

8. Sanyo Chemical Industries (Sanyo)

Headquarters: Osaka, Japan
Key Offering: Advanced super absorbent polymers for medical and industrial applications

Sanyo’s SAP division focuses on high‑performance materials for wound care, incontinence, and industrial absorbents.

Sustainability & Growth Initiatives: Research into starch‑grafted polymers, expansion of production capacity in Southeast Asia, and collaboration with research institutions on bio‑based SAPs.

• Released a new high‑absorbency polymer in 2024.
• Established a joint research program with a leading university.
• Reduced water usage in manufacturing by 25%.

9. Kuraray Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Specialty polymer solutions including bio‑based super absorbent polymers for medical use

Kuraray’s portfolio includes innovative bio‑based SAPs that meet stringent medical‑grade standards.

Sustainability & Growth Initiatives: Development of biodegradable SAPs, investment in renewable energy for production, and expansion into emerging markets.

• Launched a biodegradable SAP line in 2023.
• Partnered with a Korean hospital for clinical trials.
• Achieved carbon neutrality in 2022.

10. DuPont de Nemours & Company

Headquarters: Wilmington, USA
Key Offering: High‑performance super absorbent polymers for medical and hygiene applications

DuPont’s SAP portfolio supports wound care, incontinence, and surgical absorbent products with advanced absorption technologies.

Sustainability & Growth Initiatives: Focus on low‑toxicity formulations, collaboration with research institutions on bio‑based polymers, and investment in sustainable manufacturing practices.

• Introduced a new antimicrobial SAP for pressure ulcer management.
• Collaborated with a leading US wound‑care company on smart dressing development.
• Reduced energy consumption per ton of SAP by 18%.

Download FREE Sample Report

Get Full Report

Outlook and Future Trends (2026‑2034)

The Global medical super absorbent polymer market is poised for steady growth, with the market size projected to reach USD 1.52 billion by 2032 and continuing to expand through 2034. Key trends driving this growth include:

• Rapid adoption of bio‑based and biodegradable SAP formulations to meet sustainability mandates in North America and Europe.
• Expansion of SAP applications into specialty surgical and diagnostic settings, such as operating‑room waste solidification and wearable health‑monitoring patches.
• Strategic localization of manufacturing and distribution in Asia‑Pacific to capitalize on rising healthcare spending and aging populations.
• Increasing integration of antimicrobial agents and smart‑sensor technologies into SAP‑based dressings to enhance clinical outcomes and reduce nursing workload.
• Growing demand for high‑capacity, low‑cost SAPs in emerging economies, driven by improved healthcare infrastructure and rising disposable incomes.

In the coming decade, companies that pioneer sustainable SAP technologies and secure robust supply chains in high‑growth regions will capture significant market share and position themselves as leaders in the evolving medical absorbent landscape.